Value of contrast-enhanced ultrasound (CEUS) in Focal Liver Lesions (FLL) with inconclusive findings on cross-sectional imaging
- PMID: 31658052
- DOI: 10.3233/CH-190718
Value of contrast-enhanced ultrasound (CEUS) in Focal Liver Lesions (FLL) with inconclusive findings on cross-sectional imaging
Abstract
Background: Contrast-enhanced ultrasound (CEUS) has been used as an additional imaging technique in order to evaluate focal liver lesions. CEUS is easy and fast to perform, overcomes the limitations of B-mode US.
Objective: To evaluate the diagnostic potential of contrast-enhanced ultrasound (CEUS) in focal liver lesions (FLL) with unclear findings on computed tomography (CT) or magnetic resonance imaging (MRI).
Methods: In this single-center retrospective study, 146 patients with at least one FLL underwent additional CEUS of the liver to clarify inconclusive cross-sectional imaging findings. Ultrasonography was performed using B-mode imaging and CEUS after injection of sulphur hexafluoride microbubbles (second-generation contrast agent) within two months after ceMRI or ceCT and interpreted by an experienced radiologist (EFSUMB level 3). Histopathological reports, long-term follow-up or clinical course served as reference standard.
Results: Thirty-eight of the 146 patients had malignant and 108 benign FLL. Overall, CEUS had 92% sensitivity (95% -CI, 79-97) and 98% specificity (95% -CI, 93-99) with an AUC of 0.95 in correctly characterizing the lesion as malignant or benign. Sensitivity increased to 98% (95% -CI, 96-100) for benign lesions and decreased to 92% (95% -CI, 78-98) for malignant lesions. CEUS showed the highest diagnostical accuracy in lesion <1 cm with an AUC of 1.000, while the lowest accuracy was achieved in lesions >2 cm with an AUC of 0.924 due to a decreasing specificity of 86% (95% -CI, 87-100).
Conclusion: CEUS correctly distinguished malignant from benign FLL in cases with inconclusive cross-sectional imaging findings and achieved high levels of diagnostic accuracy. CEUS has added diagnostic value especially in small lesions ≤1 cm while specificity remains limited in larger lesions.
Keywords: CEUS; contrast-enhanced ultrasound; focal liver lesions; liver ultrasound; sonography.
Similar articles
-
Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.Ultraschall Med. 2011 Dec;32(6):593-7. doi: 10.1055/s-0031-1271114. Epub 2011 Dec 9. Ultraschall Med. 2011. PMID: 22161556
-
Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions.Expert Rev Gastroenterol Hepatol. 2018 May;12(5):479-489. doi: 10.1080/17474124.2018.1464389. Epub 2018 Apr 24. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29658347 Review.
-
Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.Swiss Med Wkly. 2019 Jun 30;149:w20087. doi: 10.4414/smw.2019.20087. eCollection 2019 Jun 17. Swiss Med Wkly. 2019. PMID: 31256416
-
Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.Ultraschall Med. 2014 Jun;35(3):259-66. doi: 10.1055/s-0033-1355728. Epub 2014 Feb 21. Ultraschall Med. 2014. PMID: 24563420
-
Contrast enhanced ultrasound for focal liver lesions: how accurate is it?Abdom Radiol (NY). 2018 May;43(5):1128-1133. doi: 10.1007/s00261-017-1257-6. Abdom Radiol (NY). 2018. PMID: 28718042 Review.
Cited by
-
Machine learning for malignant versus benign focal liver lesions on US and CEUS: a meta-analysis.Abdom Radiol (NY). 2023 Oct;48(10):3114-3126. doi: 10.1007/s00261-023-03984-0. Epub 2023 Jun 26. Abdom Radiol (NY). 2023. PMID: 37365266
-
Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: First results.Clin Hemorheol Microcirc. 2023;83(1):31-46. doi: 10.3233/CH-221449. Clin Hemorheol Microcirc. 2023. PMID: 35466932 Free PMC article.
-
Urea as a By-Product of Ammonia Metabolism Can Be a Potential Serum Biomarker of Hepatocellular Carcinoma.Front Cell Dev Biol. 2021 Apr 1;9:650748. doi: 10.3389/fcell.2021.650748. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33869206 Free PMC article.
-
Addition of contrast in ultrasound screening for hepatocellular carcinoma.Res Diagn Interv Imaging. 2024 Feb 7;9:100039. doi: 10.1016/j.redii.2023.100039. eCollection 2024 Mar. Res Diagn Interv Imaging. 2024. PMID: 39076583 Free PMC article.
-
Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease.Cancers (Basel). 2021 Feb 14;13(4):790. doi: 10.3390/cancers13040790. Cancers (Basel). 2021. PMID: 33672827 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical